Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03877276 · ClinicalTrials.gov registry record · NA

Dietary Oxalate and Immune Cell Function

A NA study of Kidney Stone, sponsored by University of Alabama at Birmingham.

Active
Registry status
NA
Development phase
82
Enrollment target
1
Study location

NCT03877276 is a NA study of Kidney Stone that is active but no longer recruiting, run by University of Alabama at Birmingham. The registered enrollment target is 82 participants, below the 190-participant average among 28 other Kidney Stone trials with a reported enrollment target (57% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03877276, a NA study of Kidney Stone, is active but no longer recruiting, sponsored by University of Alabama at Birmingham.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
82 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to evaluate mitochondrial function in white blood cells and platelets from healthy individuals following dietary oxalate intake.

Conditions Studied

Interventions

  • DIETARY_SUPPLEMENT Breakfast
  • DIETARY_SUPPLEMENT Spinach smoothie
  • DIETARY_SUPPLEMENT Kale smoothie
  • DIETARY_SUPPLEMENT Blended smoothie
  • DIETARY_SUPPLEMENT V spinach smoothie

Study Locations (1)

Alabama

  • University of Alabama at Birmingham - Birmingham

Trial Details

FieldValue
Enrollment Target 82 participants
Start Date 2016-07-21
Est. Completion 2027-12-01
Phase NA

Sponsor

University of Alabama at Birmingham

1,160 total trials

What the Registry Record Tells You About NCT03877276

The ClinicalTrials.gov registry entry for NCT03877276 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 82 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 190-participant average among 28 other Kidney Stone trials with a reported enrollment target (57% lower). The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Kidney Stone appearing as the primary indexed condition, and to 5 interventions - of which Breakfast is the first listed.

NCT03877276 reports 1 study location spanning 1 distinct geographic area - top geographies include Alabama.

Frequently Asked Questions

What is clinical trial NCT03877276 about?

NCT03877276 is a clinical study titled "Dietary Oxalate and Immune Cell Function". The purpose of this study is to evaluate mitochondrial function in white blood cells and platelets from healthy individuals following dietary oxalate intake.

What is the current status of trial NCT03877276?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 82 participants. The study started on 2016-07-21. Estimated completion is 2027-12-01.

What conditions does trial NCT03877276 study?

This clinical trial studies the following conditions: Kidney Stone.

What interventions are being tested in trial NCT03877276?

The interventions under investigation include: Breakfast (DIETARY_SUPPLEMENT), Spinach smoothie (DIETARY_SUPPLEMENT), Kale smoothie (DIETARY_SUPPLEMENT), Blended smoothie (DIETARY_SUPPLEMENT), V spinach smoothie (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT03877276?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03877276 being conducted?

This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Kidney Stone

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.